Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages
Zhenfeng Wang(Henan University), Bo Huang(Guangdong Pharmaceutical University), Yabo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Linlin Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiadi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Dan Li(Chinese Center For Disease Control and Prevention), Shunshun Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Dianheng Wang(Huazhong University of Science and Technology), Jiangning Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei‐Min Tong(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 8
Related Papers
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
|Molecular Cell|2012|3.7k
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
|Viruses|2019|1.3k